Skip to content
Medical Health Aged Care

KFNCCC Welcomes Georgina Rodríguez’s Visit to Support Young Cancer Patients

King Faisal Specialist Hospital & Research Centre 2 mins read

Rodríguez distributed specially designed "Baby Pelones" dolls to children battling cancer

Georgina Rodríguez's Visit to Children at KFNCCC - 2

RIYADH, Saudi Arabia, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The King Fahad National Centre for Children’s Cancer (KFNCCC), a subsidiary of the King Faisal Specialist Hospital and Research Centre (KFSHRC), in collaboration with the Spanish charity Juegaterapia Foundation, welcomed Georgina Rodríguez for a special visit aimed at bringing joy to young cancer patients.

Rodríguez, accompanied by Mónica Esteban, the President of Juegaterapia, distributed "Baby Pelones" dolls adorned with a unique scarf of her design. This initiative aimed to create a supportive environment in hospitals for children battling cancer, emphasising the importance of therapeutic play in promoting their emotional well-being.

Georgina Rodríguez's Visit to Children at KFNCCC - 1

The visit underscores the importance of holistic patient support within KFNCCC's commitment to pediatric care and international collaboration. Through its involvement in global social responsibility initiatives, KFNCCC reinforces its dedication to patient-centred care, significantly impacting the lives of young patients.

It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world’s top 250 Academic Medical Centres for the third consecutive year and has been recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine.

For more information, visit www.kfshrc.edu.sa or contact our media team at [email protected]

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/f58fa01b-f3b0-4218-ac15-aa134c837d0b

https://www.globenewswire.com/NewsRoom/AttachmentNg/9d7b7f84-3359-472c-b0ac-c483f728f7a8


Primary Logo

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.